Cargando…
Addition of free poloxamer 407 to a new gene vector P407-PEI-K12 solution forms a sustained-release in situ hypergel that enhances cell transfection and extends gene expression
To address the concern around the efficiency/cytotoxicity ratio and the tumor-targeting effects of polyethylenimine (PEI), is a non-viral gene vector used for the delivery of the cancer therapy gene, poloxamer 407 (P407)-PEI-K12, was synthesized by cross-linking low-molecular weight PEI with P407 an...
Autores principales: | Shu, Hongmei, Zhang, Yaguang, Zhang, Min, Wu, Junwen, Cui, Mingxiao, Liu, Kehai, Wang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396215/ https://www.ncbi.nlm.nih.gov/pubmed/30867738 http://dx.doi.org/10.3892/ol.2019.9944 |
Ejemplares similares
-
Thermogelling properties of purified poloxamer 407
por: Fakhari, Amir, et al.
Publicado: (2017) -
New Biopharmaceutical Characteristics of In Situ Systems Based on Poloxamer 407
por: Bakhrushina, Elena O., et al.
Publicado: (2023) -
Thermosensitive Polymer Blend Composed of Poloxamer 407, Poloxamer 188 and Polycarbophil for the Use as Mucoadhesive In Situ Gel
por: Hirun, Namon, et al.
Publicado: (2022) -
Thermosensitive Intravitreal In Situ Implant of Cefuroxime Based on Poloxamer 407 and Hyaluronic Acid
por: Bakhrushina, Elena O., et al.
Publicado: (2023) -
Micellar systems of poloxamer 407 and 403 for quercetin delivery
por: Araujo, Juscemácia, et al.
Publicado: (2014)